In a touching announcement that has resonated across Latin America, Colombian actress and writer Alina Lozano revealed she is expecting a baby at the age of 55. The news marks a deeply meaningful milestone for Lozano and her 24-year-old husband, actor Jim Velasquez, as they prepare to expand their unconventional but inspiring family.
Lozano, widely known for her work in Colombian television and theater, married Velasquez in November 2023. Their 31-year age difference sparked public debate, with some questioning their relationship, but many celebrated their bond as a true testament to love transcending age. United by a shared passion for the arts and mutual respect, the couple built a strong and supportive partnership.
Determined to become parents together, Lozano and Velasquez turned to fertility treatments—a process requiring not only emotional resilience but significant financial investment. Spending nearly 100 million Colombian pesos (approximately €21,700), they pursued specialized care to make their dream a reality. The joyful result: a successful pregnancy, which Lozano lovingly described as their “little miracle.”

The announcement has drawn praise from fans and supporters, many applauding Lozano’s honesty and bravery in embracing motherhood later in life. Her story challenges traditional ideas about family and age, offering hope to others who may feel limited by societal expectations. Through sharing her journey, Lozano sheds light on both the challenges and possibilities that modern fertility treatments offer—especially for women choosing a different timeline for motherhood.
As they await the arrival of their child, Lozano and Velasquez continue to share their excitement with their audience. Their story isn’t just about becoming parents—it’s about resilience, love, and rewriting the rules of what family can look like in today’s world.
For Alina Lozano and Jim Velasquez, this moment is a celebration of new beginnings, a testament to unwavering hope, and a reminder that it’s never too late to follow your heart.